Lineagen, National Multiple Sclerosis Society deal

Lineagen partnered with the society's Fast Forward LLC not-for-profit subsidiary to develop a blood-based assay to diagnose multiple sclerosis. Fast Forward will commit $622,000 to establish and valid...